Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

CUSIP: 53566P109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common shares
Shares outstanding
250,425,788
Total 13F shares
73,975,180
Share change
-2,164,354
Total reported value
$181,237,026
Put/Call ratio
20%
Price per share
$2.45
Number of holders
110
Value change
-$5,349,258
Number of buys
41
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 53566P109?
CUSIP 53566P109 identifies LCTX - Lineage Cell Therapeutics, Inc. - Common shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BROADWOOD CAPITAL INC
13F
Company
14%
34,005,379
$85,694,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
3.4%
8,551,699
$21,550,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
2.4%
5,956,634
$15,011,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
2.2%
5,458,451
$13,755,000 30 Sep 2021
13F
Defender Capital, LLC.
13F
Company
1.9%
4,798,270
$12,707,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.94%
2,341,514
$5,900,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.88%
2,215,792
$5,584,000 30 Sep 2021
13F
Prescott General Partners LLC
13F
Company
0.74%
1,851,851
$4,667,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.6%
1,497,627
$3,774,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.44%
1,112,366
$2,803,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.28%
704,430
$1,776,000 30 Sep 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.23%
580,788
$1,464,000 30 Sep 2021
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.22%
550,000
$1,390,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.18%
441,591
$1,126,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.17%
424,966
$1,071,000 30 Sep 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0.14%
359,377
$913,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
315,354
$795,000 30 Sep 2021
13F
STRS OHIO
13F
Company
0.11%
282,700
$712,000 30 Sep 2021
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.09%
228,266
$575,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0.08%
207,702
$523,000 30 Sep 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.08%
193,756
$488,000 30 Sep 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.07%
187,486
$472,000 30 Sep 2021
13F
LINCOLN NATIONAL CORP
13F
Company
0.06%
154,600
$390,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
0.06%
137,858
$347,000 30 Sep 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.05%
128,683
$324,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.05%
125,027
$316,000 30 Sep 2021
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.05%
124,219
$313,000 30 Sep 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
119,701
$302,000 30 Sep 2021
13F
Value Partners Investments Inc.
13F
Company
0.05%
120,000
$301,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
118,723
$299,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.05%
115,691
$292,000 30 Sep 2021
13F
Laidlaw Wealth Management LLC
13F
Company
0.04%
104,841
$264,000 30 Sep 2021
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.04%
100,927
$254,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
97,071
$245,000 30 Sep 2021
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.04%
96,762
$244,000 30 Sep 2021
13F
RAFFLES ASSOCIATES LP
13F
Company
0.04%
93,590
$236,000 30 Sep 2021
13F
LPL Financial LLC
13F
Company
0.03%
87,580
$221,000 30 Sep 2021
13F
DCF Advisers, LLC
13F
Company
0.03%
87,000
$219,000 30 Sep 2021
13F
SG Americas Securities, LLC
13F
Company
0.03%
75,780
$191,000 30 Sep 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.03%
74,991
$189,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
72,135
$182,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
71,856
$181,000 30 Sep 2021
13F
Strategic Wealth Investment Group, LLC
13F
Company
0.03%
70,625
$179,000 30 Sep 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
69,150
$174,000 30 Sep 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
68,642
$173,000 30 Sep 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
65,203
$164,000 30 Sep 2021
13F
WINTON GROUP Ltd
13F
Company
0.03%
62,869
$158,000 30 Sep 2021
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
62,549
$158,000 30 Sep 2021
13F
SIMPLEX TRADING, LLC
13F
Company
0.02%
51,383
$146,000 30 Sep 2021
13F
Invesco Ltd.
13F
Company
0.02%
55,643
$140,000 30 Sep 2021
13F

Institutional Holders of Lineage Cell Therapeutics, Inc. - Common shares (LCTX) as of Q4 2021

As of 31 Dec 2021, Lineage Cell Therapeutics, Inc. - Common shares (LCTX) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,975,180 shares. The largest 10 holders included BROADWOOD CAPITAL INC, BlackRock Inc., VANGUARD GROUP INC, Defender Capital, LLC., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Prescott General Partners LLC, JPMORGAN CHASE & CO, TWO SIGMA ADVISERS, LP, and NORTHERN TRUST CORP. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
106
Q4 2021 holders
110
Holder diff
4
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .